Status:
COMPLETED
Exposure Therapy Consortium (ETC) for Anxiety Sensitivity
Lead Sponsor:
University of Texas at Austin
Collaborating Sponsors:
University of North Carolina, Chapel Hill
University of Colorado, Boulder
Conditions:
Elevated Anxiety Sensitivity
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The current study seeks to test differences between a single-session large-group format of standard exposure, enhanced exposure, and a control condition in treating anxiety sensitivity. It is hypothes...
Detailed Description
Anxiety sensitivity (AS), or the fear of anxiety and related sensations, represents an individual difference variable implicated in the risk and maintenance of anxiety and related disorders. Best conc...
Eligibility Criteria
Inclusion
- Ages 18-70
- Students currently enrolled in enrolled in an introductory psychology course a psychology course
- Elevated anxiety sensitivity (total ASI-3 score ≥ 23)
Exclusion
- \- History of respiratory or cardiovascular conditions (e.g., asthma, high blood pressure), neurological disorders (e.g., epilepsy), current pregnancy, or medical problems (e.g., inner ear problems, back or joint problems) that may interfere with an ability complete interoceptive exposure procedures
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
399 Patients enrolled
Trial Details
Trial ID
NCT05225740
Start Date
October 1 2022
End Date
July 1 2024
Last Update
April 29 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Colorado at Boulder
Boulder, Colorado, United States, 80309
2
The University of Miami
Miami, Florida, United States, 33146
3
Boston University
Boston, Massachusetts, United States, 02215
4
The University of Mississippi
Oxford, Mississippi, United States, 38677